NasdaqGS - Nasdaq Real Time Price • USD
Merit Medical Systems, Inc. (MMSI)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 0.71 | 0.88 | 3.32 | 3.64 |
| Low Estimate | 0.71 | 0.84 | 3.3 | 3.46 |
| High Estimate | 0.72 | 0.91 | 3.34 | 3.78 |
| Year Ago EPS | 0.64 | 0.81 | 3.01 | 3.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 9 | 10 | 10 |
| Avg. Estimate | 315.51M | 337.05M | 1.32B | 1.39B |
| Low Estimate | 313.6M | 335.1M | 1.32B | 1.39B |
| High Estimate | 316.6M | 340.49M | 1.32B | 1.4B |
| Year Ago Sales | -- | 310.45M | 1.26B | 1.32B |
| Sales Growth (year/est) | -- | 8.60% | 5.00% | 5.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.55 | 0.75 | 0.65 | 0.76 |
| EPS Actual | 0.64 | 0.81 | 0.75 | 0.81 |
| Difference | 0.09 | 0.06 | 0.1 | 0.05 |
| Surprise % | 16.40% | 8.00% | 15.40% | 6.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.71 | 0.88 | 3.32 | 3.64 |
| 7 Days Ago | 0.71 | 0.88 | 3.32 | 3.64 |
| 30 Days Ago | 0.71 | 0.88 | 3.31 | 3.64 |
| 60 Days Ago | 0.71 | 0.9 | 3.32 | 3.65 |
| 90 Days Ago | 0.7 | 0.89 | 3.29 | 3.64 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MMSI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 10.90% | -- | -- | 5.40% |
| Next Qtr. | 8.60% | -- | -- | 10.90% |
| Current Year | 10.30% | -- | -- | 4.50% |
| Next Year | 9.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 10.25% | -- | -- | 10.94% |
| Past 5 Years (per annum) | 19.31% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barrington Research: Outperform to Outperform | 4/16/2024 |
| Initiated | CL King: Buy | 4/11/2024 |
| Reiterates | Needham: Buy to Buy | 4/11/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 2/29/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 2/29/2024 |
| Maintains | Needham: Buy to Buy | 2/29/2024 |
Related Tickers
ICUI ICU Medical, Inc.
94.84
+0.33%
AZTA Azenta, Inc.
52.18
+1.32%
ATRI Atrion Corporation
395.01
-0.99%
STVN Stevanato Group S.p.A.
27.54
+0.07%
HAE Haemonetics Corporation
90.99
+3.80%
ANGO AngioDynamics, Inc.
5.81
+0.52%
UTMD Utah Medical Products, Inc.
65.92
-0.56%
TFX Teleflex Incorporated
206.71
0.00%
OSUR OraSure Technologies, Inc.
5.32
+1.14%
ANIK Anika Therapeutics, Inc.
25.57
-0.04%